Benefits
Energy expenditure after a dose of grains of paradise extract
No trial has given pure 6-paradol to people. In a crossover study of 19 young men, one 40 mg dose of grains of paradise seed extract raised energy expenditure within 2 hours more in the 12 men with active brown fat than in the 7 without, and placebo had no effect. The full text gives the extract as 12.5 percent 6-paradol, about 5 mg per dose, alongside more 6-gingerol.
Cold-induced thermogenesis with daily extract use
In 9 young men picked for low brown fat activity, 40 mg a day of grains of paradise extract for 5 weeks raised cold-induced thermogenesis compared with placebo, while resting energy expenditure did not change. In 19 young women, 30 mg a day for 4 weeks raised energy expenditure while placebo did not. Both were small, single-blind crossover studies of an extract with 12.5 percent 6-paradol.
Visceral fat and body weight in standardized extract trials
In a 12-week maker-authored trial in 70 overweight adults, 500 mg a day of an extract with 2 percent 6-paradol lowered visceral fat area and weight versus placebo (mean loss 4.1 vs 0.8 kg, median 1.6 vs 0.4 kg), but DXA fat mass did not differ and lean mass fell. In a sponsor-funded 8-week diet and exercise trial, 40 mg of a branded extract plus L-BAIBA did no better than placebo on weight, fat or resting metabolic rate.
Brown fat heat production and fat gain in rodent studies
This is animal work. In rats, isolated 6-paradol given into the stomach raised sympathetic nerve firing to brown fat for up to 3 hours and warmed the tissue. In mice on a high-fat diet, 6-paradol reduced weight gain and visceral fat over 2 weeks while 6-gingerol and 6-shogaol did not, and it outperformed dihydrocapsiate over 8 weeks.
Glucose use in cell and mouse studies
This is laboratory and animal work. In fat and muscle cells, 6-paradol and 6-shogaol increased glucose use, linked in fat cells to higher AMPK activation, and in mice fed a high-fat diet 6-paradol lowered blood glucose, cholesterol and body weight. No human study has measured blood sugar with 6-paradol.
Mechanism of action
Activates the TRPV1 and TRPA1 pungency sensors
In sensory neurons and in cells engineered to carry the channels, 6-paradol activated TRPV1, the capsaicin receptor, and TRPA1, two channels behind hot and burning sensations. This explains its peppery bite; whether it drives the thermogenic readings in people has not been shown.
Sympathetic signaling to brown fat
In rats, 6-paradol and grains of paradise extract raised sympathetic nerve discharge to brown fat, and mouse work tied 6-paradol to more UCP1, the heat-producing protein of brown fat. A later rat study found that the whole extract and 6-gingerol lowered that nerve activity, so the pathway is not settled. These are animal findings.
Fat-storage genes in liver and fat tissue
In mice on a high-fat diet, 6-paradol lowered liver cholesterol and triglycerides and reduced the activity of genes for fat synthesis, lipid transport and fat-cell formation in liver and fat tissue. Unlike 6-gingerol, it did not raise AMPK activation in this study (a separate fat-cell study did find it), so the authors proposed an AMPK-independent route. Animal work only.
Absorption and the gut wall
In rats given paradols by mouth, blood levels of their metabolites fell as the side chain got longer, pointing to lower absorption, and the authors proposed the intestinal wall as the main site of action. How much 6-paradol people absorb from a capsule has not been measured.
Clinical trials
Single-blind, randomized, placebo-controlled crossover study of one 40 mg oral dose of grains of paradise seed extract, a source of 6-paradol, 6-gingerol and 6-shogaol; brown fat status was assessed by FDG-PET after 2 hours of cold at 19 C and energy expenditure by indirect calorimetry. (Sugita et al. 2013, Br J Nutr)
19 healthy men aged 20 to 32; 12 had detectable brown fat and 7 did not.
Resting energy expenditure did not differ between the groups at baseline. After the extract, energy expenditure rose within 2 hours to a significantly higher level in the brown-fat-positive men than in the negative men (P<0.01); placebo produced no significant change. The full text reports the extract as 12.5 percent 6-paradol and 15.2 percent 6-gingerol, so the dose held about 5 mg of 6-paradol. An acute reading in a small group with no body-weight outcome.
Single-blind, randomized, placebo-controlled crossover study of 30 mg a day of grains of paradise seed extract (12.5 percent 6-paradol per the full text, about 3.75 mg a day) for 4 weeks, with whole-body energy expenditure and body fat (visceral fat by CT at the navel) measured before and after each period. (Sugita et al. 2014, J Nutr Sci Vitaminol (Tokyo))
19 non-obese women aged 20 to 22.
Visceral fat area fell with the extract and rose slightly on placebo, a significant difference (p<0.05) that was larger in women with more visceral fat at the start (r=-0.64). Subcutaneous and total fat did not change with either. Energy expenditure rose with the extract (p<0.05) but not placebo. Surrogate outcomes in a small group, not weight loss.
Single-blind, randomized, placebo-controlled crossover study of 40 mg a day of grains of paradise seed extract (four 10 mg capsules each holding 1.25 mg of 6-paradol, so 5 mg a day) for 5 weeks in men screened by FDG-PET/CT for low brown fat activity, with cold-induced thermogenesis and body composition measured before and after. (Yoneshiro et al. 2021, J Nutr Sci Vitaminol (Tokyo))
9 healthy young men with reduced brown fat activity.
Cold-induced thermogenesis after treatment was significantly higher with the extract than with placebo, while resting energy expenditure at a neutral temperature did not change. Body weight and fat-free mass did not change significantly; body fat percentage fell slightly but significantly with the extract only. A very small study.
Randomized, double-blind, placebo-controlled trial of a grains of paradise seed extract containing not less than 2 percent 6-paradol (AfperFit), 250 mg twice daily for 12 weeks, each capsule holding 5 mg of 6-paradol, so 10 mg a day; energy expenditure by indirect calorimetry, body composition by DEXA, fat distribution by CT. Two of the four authors, including the corresponding author, are employed by Vidya Herbs, which produces AfperFit; the paper has no funding statement. (Sudeep et al. 2022, Drug Des Devel Ther)
70 overweight men and women (BMI 25 to 30) aged 20 to 50; 35 per group.
Energy expenditure rose (p<0.01) and visceral fat area and the visceral-to-subcutaneous fat ratio fell versus placebo. Mean weight change was -4.07 kg with the extract versus -0.81 kg with placebo (p<0.01), but the medians were -1.6 and -0.4 kg, so a few large losses pulled the mean up. DXA fat mass and body fat percentage did not differ from placebo, and lean mass fell with the extract but rose on placebo (p=0.002). Ten of 70 were lost to follow-up and analyzed by last observation carried forward. No adverse effects were reported and safety labs stayed normal. Not independently repeated.
Randomized, double-blind, placebo-controlled trial of 500 mg L-BAIBA alone or 500 mg L-BAIBA plus 40 mg of a grains of paradise extract (CaloriBurn) daily for 56 days, alongside a calorie-reduced diet and weekly exercise; there was no extract-only arm. Funded by NNB Nutrition, which sells both ingredients, and the senior author is a paid advisor to the sponsor. (Allen et al. 2026, Nutr J)
37 overweight or obese adults (mostly women) completed: 12 placebo, 13 L-BAIBA, 12 L-BAIBA plus extract.
No significant group-by-time differences in body mass, resting metabolic rate, DXA fat mass, fat-free mass or percent fat, appetite, energy or focus ratings, heart rate, blood pressure, glucose or blood lipids. Hunger ratings were lower than placebo at day 28 in the L-BAIBA plus extract group. All three groups lost a similar amount of weight and fat over the program. L-BAIBA alone lowered hunger at more time points than the combination. Because the extract was always given with L-BAIBA, its own effect cannot be separated.